Ticker Details
Tango Therapeutics, Inc.
IPO Date:	September 3, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.93B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.28 | 3.83%
Avg Daily Range (30 D):	$0.89 | 3.78%
Avg Daily Range (90 D):	$0.64 | 3.69%

Institutional Daily Volume
Avg Daily Volume:	.88M
Avg Daily Volume (30 D):	2.82M
Avg Daily Volume (90 D):	2.9M

Trade Size
Avg Trade Size (Sh.):	111
Avg Trade Size (Sh.) (30 D):	90
Avg Trade Size (Sh.) (90 D):	97

Institutional Trades
Total Institutional Trades:	1,449
Avg Institutional Trade:	$1.95M
Avg Institutional Trade (30 D):	$2.42M
Avg Institutional Trade (90 D):	$2.33M
Avg Institutional Trade Volume:	.19M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.39M
Avg Closing Trade (30 D):	$5.51M
Avg Closing Trade (90 D):	$4.99M
Avg Closing Volume:	238.32K

News

Mar 19, 2026 @ 3:00 PM The Patent Cliff is Coming, Driving Smart Money To... Source: Equity-Insider.Com

Mar 6, 2026 @ 10:33 PM Tango Therapeutics Announces Inducement Grants Und... Source: Na

Mar 4, 2026 @ 11:15 PM Investment Firm Bets Big on TNGX Stock With $9.5 M... Source: Jake Lerch

Jan 5, 2026 @ 12:00 PM Tango Therapeutics Appoints Sung Lee to Board of D... Source: Na

Aug 26, 2025 @ 11:00 AM Tango Therapeutics to Participate in the 2025 Cant... Source: Barbara Weber, M.D.

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.83	$-.32	$-.3
Diluted EPS	$-.84	$-.32	$-.3
Revenue	$56.99M	$M	$M
Gross Profit
Net Income / Loss	$-107.23M	$-45.51M	$-38.75M
Operating Income / Loss	$-117.53M	$-48.77M	$-41.86M
Cost of Revenue
Net Cash Flow	$98.97M	$45.12M	$53.94M
PE Ratio